Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Xiang Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, Children's Hospital affiliated to Shandong University, Jinan, China. Hauptthemen laut MEDLINE: COVID-19, Asthma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The global spread of coronavirus disease 2019 (COVID‐19) has resulted in a significant disease burden, yet asthma patients do not have the expected high morbidity and mortality rates in the pandemics of COVID‐19.
Objective
To find the difference of angiotensin‐converting enzyme 2 (ACE2) in asthma and nonasthma children and evaluate the effect of inhaled corticosteroids (ICS) on its expression.
Methods
The ACE2, immunoglobulin E (IgE), and eosinophils were tested in different children.
Results
A total of 157 children aged 3–16 years were enrolled. The expression of ACE2 in asthma children were lower than nonasthma children ( T = −2.512, p = .013). Allergic nonasthma children had a significant higher ACE2 expression than children with allergic asthma ( p = .013) and nonallergic asthma ( p = .029). The expression of ACE2 had no significant difference between first‐diagnosed asthma children and that had been treated with ICS for ≥6 months ( F = 0.028, p = .598). The allergic asthma children showed a significantly higher eosinophils cells (EC) count than the allergic nonasthma ( W = 200, p < .001) and nonallergic nonasthma children ( W = 1089, p < .001). Nonallergic asthma children also had a significant higher EC count than the allergic non‐asthma ( W = 182.5, p < .001) and nonallergic non‐asthma ( W = 200.5, p < .001) children. There was no significant difference in IgE levels between asthmatic children and non‐asthmatic children ( W = 2792.5, p = .18).
Conclusion
Circulating ACE2 levels in asthmatic children were lower than those in non‐asthmatic children and ICS treatment for ≥6 months did not affect the expression of ACE2 in peripheral blood in the asthma children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Diseases, Children's Hospital affiliated to Shandong University, Jinan, China.
- Jinan Key Lab of Respiratory Diseases for Children, Jinan Children's Hospital, Jinan, China.
- Department of Infectious Diseases, Huaiyin People's Hospital, Jinan, China.
ORCID-Profile: Xiang Ma
Zitieren
APA
Ma, X., Liu, L., Sun, J., Zhang, Y., Liu, Y., Liu, M., Wang, B., Chang, Y., Han, Y., & Gai, Z. (2023). Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.922
Vancouver
Ma X, Liu L, Sun J, Zhang Y, Liu Y, Liu M, et al. Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.922
BibTeX
@article{Ma2023,
author = {Ma, Xiang and Liu, Lesen and Sun, Jing and Zhang, Yun and Liu, Yanqin and Liu, Miao and Wang, Bing and Chang, Yuna and Han, Yuling and Gai, Zhongtao},
title = {Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.922}
}
EUVIMED